Allspring Global Investments Holdings LLC reduced its stake in Prologis by 1% in Q1, selling 4,536 shares. Other ...

Cidel Asset Management reduced its Citigroup holdings by 9.1% in the first quarter, selling 3,032 shares valued at $2.16 ...

Boeing's stock slipped 1.1% despite a notable 76% drop in trading volume, closing at $207.26 after hitting a low of $207.70.

DAVENPORT & Co LLC slightly boosted its stake in The TJX Companies by purchasing 2,428 additional shares in Q1, bringing ...

KBC Group NV increased its stake in Deere & Company by 1% in Q1, signaling steady institutional interest in the industrial ...

Spire Wealth Management increased its Airbnb holdings by 40.1% in Q1, buying an additional 260 shares. This brings their ...

Vertex Pharmaceuticals secured EU approval for ALYFTREK, a next-gen cystic fibrosis therapy boasting a better efficacy ...

Lockheed Martin will release its second quarter 2025 earnings results on July 22, with a live webcast at 11 a.m. ET. James ...

Bessemer Group significantly trimmed its investment in Regeneron Pharmaceuticals during the first quarter, slashing its stake ...

Bristol-Myers Squibb is running a rigorous Phase 2/3 clinical trial on ozanimod, aiming to help children with moderate to severe ulcerative colitis who haven’t responded to conventional treatments.

Cigna has announced that starting September 15, 2025, it will begin covering RhinAer, a minimally invasive treatment for chronic rhinitis. This update means RhinAer is no longer classified as ...

Capital Advisors Wealth Management LLC nearly doubled its Starbucks stake in Q1, upping its share count by 90.1% to 6,812.